Kathleen Burnley
Family Medicine · Richmond, VANPI 1528034865
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.8% of the total across 95 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 16.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,745, more than ten times the $18 reported in 2019.
Across 95 payments — averaging $20.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$317
- Novo Nordisk$295
- Lilly USA, LLC$147
- AstraZeneca$139
- Astellas Pharma US Inc$137
- Johnson & Johnson$100
- plus $773 from 20 others
What the payments were for
- Food & beverage$1,80995%
- Education$1005%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,909 in reported general payments places this provider in the 75th percentile of 2,553 family medicine providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humulin 70/30 KwikpenInsulin Nph Hum/Reg Insulin Hm | 16 | $3,248 |
| Humulin 70-30Insulin Nph Hum/Reg Insulin Hm | 16 | $3,011 |
| Levothyroxine Sodium | 25 | $337 |
| Pantoprazole Sodium | 14 | $275 |
| Gabapentin | 25 | $235 |
| Atorvastatin Calcium | 42 | $156 |
| Rosuvastatin Calcium | 41 | $129 |
| Metoprolol Succinate | 20 | $121 |
| Metformin Hcl | 35 | $83 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 19 | $66 |
| Amlodipine Besylate | 40 | $56 |
| Lisinopril | 40 | $42 |
| Omeprazole | 20 | $36 |
| Montelukast Sodium | 12 | $30 |
| Hydrochlorothiazide | 20 | $30 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCHumulin 70-30 | $147 | $3,01116 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $28 | $33725 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,553 family medicine providers in Virginia.
Other family medicine in Richmond
- Paul StairsRichmond$105K
- Edwin RobinsonRichmond$83K
- James FosterRichmond$27K
- Daniel DavidRichmond$16K
- Douglas KlassettRichmond$16K
- James ZelenakRichmond$15K
- David SteinRichmond$15K
- Richard TateRichmond$14K
- Oluwaronke AwosikaFort Gregg Adams$397K
- Monique MatuskowitzNorfolk$110K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.